Yanbing Li

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 23

Top Topics

Decision Making

Newly Diagnosed

Glycemic Control

Top Venues

Journal of diabetes

Endocrine connections

This page only lists publications with an associated author ORCID identifier.

Publications

Weiwei Liang, Yilin Zhang, Yan Guo, Pengyuan Zhang, Jiewen Jin, Hongyu Guan, Yanbing Li
FLNA overexpression promotes papillary thyroid cancer aggression via the FAK/AKT signaling pathway. Endocrine connections 13 (6) (2024)
Jinmei Deng, Yanglei Cheng, Hai Li, Xiaoying He, Shuang Yu, Jiajing Ma, Xuhui Li, Jie Chen, Haipeng Xiao, Hongyu Guan, Yanbing Li
PFKFB3 facilitates cell proliferation and migration in anaplastic thyroid carcinoma via the WNT/β-catenin signaling pathway. Endocrine (2024)
Jiajing Ma, Xuhui Li, Xuesi Wan, Jinmei Deng, Yanglei Cheng, Boyuan Liu, Liehua Liu, Lijuan Xu, Hai-Peng Xiao, Yanbing Li
Single-Cell RNA-seq Analysis Reveals a Positive Correlation between Ferroptosis and Beta-Cell Dedifferentiation in Type 2 Diabetes. Biomedicines 12 (8) (2024)
Jinmei Deng, Yanglei Cheng, Hai Li, Xiaoying He, Shuang Yu, Jiajing Ma, Xuhui Li, Jie Chen, Haipeng Xiao, Hongyu Guan, Yanbing Li
PFKFB3 facilitates cell proliferation and migration in anaplastic thyroid carcinoma via the WNT/β-catenin signaling pathway. Endocrine 85 (2) (2024)
Jiajing Ma, Xuhui Li, Xuesi Wan, Jinmei Deng, Yanglei Cheng, Boyuan Liu, Liehua Liu, Lijuan Xu, Hai-Peng Xiao, Yanbing Li
Single-Cell RNA-seq Analysis Reveals a Positive Correlation between Ferroptosis and Beta-Cell Dedifferentiation in Type 2 Diabetes. Biomedicines 12 (8) (2024)
Jinmei Deng, Yanglei Cheng, Hai Li, Xiaoying He, Shuang Yu, Jiajing Ma, Xuhui Li, Jie Chen, Haipeng Xiao, Hongyu Guan, Yanbing Li
PFKFB3 facilitates cell proliferation and migration in anaplastic thyroid carcinoma via the WNT/β-catenin signaling pathway. Endocrine 85 (2) (2024)
Weiwei Liang, Yilin Zhang, Yan Guo, Pengyuan Zhang, Jiewen Jin, Hongyu Guan, Yanbing Li
FLNA overexpression promotes papillary thyroid cancer aggression via the FAK/AKT signaling pathway. Endocrine connections 13 (6) (2024)
Weiwei Liang, Yilin Zhang, Yan Guo, Pengyuan Zhang, Jiewen Jin, Hongyu Guan, Yanbing Li
FLNA overexpression promotes papillary thyroid cancer aggression via the FAK/AKT signaling pathway. Endocrine connections 13 (6) (2024)
Weiwei Liang, Yilin Zhang, Yan Guo, Pengyuan Zhang, Jiewen Jin, Hongyu Guan, Yanbing Li
FLNA overexpression promotes papillary thyroid cancer aggression via the FAK/AKT signaling pathway. Endocrine connections 13 (6) (2024)
Weiman He, Zhen Cheng, Zijun Huo, Bo Lin, Xuejie Wang, Yijia Sun, Shuang Yu, Siting Cao, Junyu Xue, Rengyun Liu, Weiming Lv, Yanbing Li, Shubin Hong, Hai-Peng Xiao
STRA6 promotes thyroid carcinoma progression via activation of the ILK/AKT/mTOR axis in cells and female nude mice. Endocrinology (2023)
Weiman He, Zhen Cheng, Zijun Huo, Bo Lin, Xuejie Wang, Yijia Sun, Shuang Yu, Siting Cao, Junyu Xue, Rengyun Liu, Weiming Lv, Yanbing Li, Shubin Hong, Hai-Peng Xiao
STRA6 Promotes Thyroid Carcinoma Progression via Activation of the ILK/AKT/mTOR Axis in Cells and Female Nude Mice. Endocrinology 164 (3) (2023)
Liehua Liu, Weijian Ke, Lijuan Xu, Hai Li, Juan Liu, Xuesi Wan, Jianbin Liu, Wanping Deng, Xiaopei Cao, Hai-Peng Xiao, Yanbing Li
Evaluating the role of time in range as a glycemic target during short-term intensive insulin therapy in patients with newly diagnosed type 2 diabetes. Journal of diabetes 15 (2) (2023)
Liehua Liu, Weijian Ke, Lijuan Xu, Hai Li, Juan Liu, Xuesi Wan, Jianbin Liu, Wanping Deng, Xiaopei Cao, Hai-Peng Xiao, Yanbing Li
Evaluating the role of time in range as a glycemic target during short-term intensive insulin therapy in patients with newly diagnosed type 2 diabetes. Journal of diabetes 15 (2) (2023)
Liehua Liu, Weijian Ke, Lijuan Xu, Hai Li, Juan Liu, Xuesi Wan, Jianbin Liu, Wanping Deng, Xiaopei Cao, Hai-Peng Xiao, Yanbing Li
Evaluating the role of time in range as a glycemic target during short-term intensive insulin therapy in patients with newly diagnosed type 2 diabetes. Journal of diabetes 15 (2) (2023)
Liehua Liu, Weijian Ke, Lijuan Xu, Hai Li, Juan Liu, Xuesi Wan, Jianbin Liu, Wanping Deng, Xiaopei Cao, Hai-Peng Xiao, Yanbing Li
Evaluating the role of time in range as a glycemic target during short-term intensive insulin therapy in patients with newly diagnosed type 2 diabetes. Journal of diabetes 15 (2) (2023)
Weiman He, Zhen Cheng, Zijun Huo, Bo Lin, Xuejie Wang, Yijia Sun, Shuang Yu, Siting Cao, Junyu Xue, Rengyun Liu, Weiming Lv, Yanbing Li, Shubin Hong, Hai-Peng Xiao
STRA6 Promotes Thyroid Carcinoma Progression via Activation of the ILK/AKT/mTOR Axis in Cells and Female Nude Mice. Endocrinology 164 (3) (2023)
Liehua Liu, Weijian Ke, Lijuan Xu, Hai Li, Juan Liu, Xuesi Wan, Jianbin Liu, Wanping Deng, Xiaopei Cao, Hai-Peng Xiao, Yanbing Li
Evaluating the role of time in range as a glycemic target during short-term intensive insulin therapy in patients with newly diagnosed type 2 diabetes. Journal of diabetes (2023)
Wenjing Ye, Lijuan Xu, Yanbin Ye, Fangfang Zeng, Xin Lu, Yanbing Li, Liehua Liu
The efficacy and safety of meal replacement in patients with type 2 diabetes: a systematic review and meta-analysis. The Journal of clinical endocrinology and metabolism (2023)
Nan Chen, Yan Chen, Fenghua Lai, Li Chen, Rui Zeng, Ling Pei, Li Ting Wu, Chenxue Wang, Yanbing Li, Hai-Peng Xiao, Xiaopei Cao
Circulating GLP-1 Levels in Patients with Pheochromocytoma/Paraganglioma. International journal of endocrinology 2022 (2022)
Wei Xian, Dide Wu, Boyuan Liu, Shubin Hong, Zijun Huo, Hai-Peng Xiao, Yanbing Li
Graves' disease and inflammatory bowel disease: A bidirectional Mendelian randomization. The Journal of clinical endocrinology and metabolism (2022)
Chenhong Lin, Xiaoying He, Xueying Chen, Liehua Liu, Hongyu Guan, Haipeng Xiao, Yanbing Li
miR-1275 Inhibits Human Omental Adipose-Derived Stem Cells Differentiation Toward the Beige Phenotype via PRDM16 . Stem cells and development (2022)
Nan Chen, Yan Chen, Fenghua Lai, Li Chen, Rui Zeng, Ling Pei, Li Ting Wu, Chenxue Wang, Yanbing Li, Hai-Peng Xiao, Xiaopei Cao
Circulating GLP-1 Levels in Patients with Pheochromocytoma/Paraganglioma. International journal of endocrinology 2022 (2022)
Yuxin Chen, Hai Li, Weiwei Liang, Yan Guo, Miaoguan Peng, Wen Ke, Haipeng Xiao, Hongyu Guan, Yanbing Li
SLC6A15 acts as a tumor suppressor to inhibit migration and invasion in human papillary thyroid cancer. Journal of cellular biochemistry 122 (8) (2021)